Publications by authors named "Grit Hutter"

Claim this Profile
T
Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell lines.
Anna-Katharina Zoellner, Nico Peter, Yvonne Zimmermann, Grit Hutter, Wolfgang Hiddemann

Eur J Haematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathway.
Anna-Katharina Zoellner, Stephan Bayerl, Grit Hutter, Yvonne Zimmermann, Wolfgang Hiddemann

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.
Till Seiler, Grit Hutter, Martin Dreyling

Drugs· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temsirolimus acts as additive with bendamustine in aggressive lymphoma.
Anna-Katharina Zoellner, Tobias Weiglein, Grit Hutter, Yvonne Zimmermann, Hans Christian Cieplik

Ann Hematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.
Daniel A Heinrich, Marc Weinkauf, Grit Hutter, Yvonne Zimmermann, Vindi Jurinovic

Br J Haematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Martin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, Wolfram Klapper, Niclas Vogt, Grit Hutter

Leuk Lymphoma· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma.
Grit Hutter, Malte Rieken, Alessandro Pastore, Oliver Weigert, Yvonne Zimmermann

Ann Hematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
Martin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, Elena Hartmann, Itziar Salaverria, Grit Hutter

Leuk Lymphoma· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
Martin Dreyling, Eva Hoster, Silvia Bea, Elena Hartmann, Heike Horn, Grit Hutter

Leuk Lymphoma· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined RNA-expression and 2D-PAGE-screening identifies comprehensive interaction networks affected after bortezomib or enzastaurin exposure of mantle cell lymphoma.
Marc Weinkauf, Grit Hutter, Yvonne Zimmermann, Elena Hartmann, Andreas Rosenwald

Talanta· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3'UTR mediated regulation of the cyclin D1 proto-oncogene.
Anagha Deshpande, Alessandro Pastore, Aniruddha J Deshpande, Yvonne Zimmermann, Grit Hutter

Cell Cycle· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma.
Marc Weinkauf, Yvonne Zimmermann, Elena Hartmann, Andreas Rosenwald, Malte Rieken, Grit Hutter

Electrophoresis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.
Heike Stöcklein, Grit Hutter, Jörg Kalla, Elena Hartmann, Yvonne Zimmermann

J Hematop· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Grit Hutter, Miriam Scheubner, Yvonne Zimmermann, Joerg Kalla, Tiemo Katzenberger

Genes Chromosomes Cancer· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Georg Lenz, Grit Hutter, Wolfgang Hiddemann, Martin Dreyling

Ann Hematol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines.
Grit Hutter, Christina Nickenig, Henk Garritsen, Frank Hellenkamp, Andre Hoerning

Hematol J· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis